We were delighted to speak to Professor Carmelo Rizzari, President of the European Society of Paediatric Oncology (SIOP Europe), who summarized the structure, organisation and goals of the society, and why the Annual Meeting took place virtually in March 2022. Questions Please summarize the organization, structure and remits of SIOPE? (01:00-03:09) Why did the SIOP […]

It was a pleasure to speak with Professor Carmelo Rizzari, President of the European Society of Paediatric Oncology (SIOP Europe), who explained why the concept of the SIOP Europe Annual Meeting is different to other scientific congresses. Speaker Disclosure: Speaker Disclosure: Carmelo Rizzari has been a consultant for Jazz Pharmaceutcials, Amgen, Servier and Clinigen. He […]

Professor Carmelo Rizzari, President of the European Society of Paediatric Oncology (SIOP Europe), explains who the Annual Meeting is aimed at, who is involved and what were the main take-away messages from this year’s conference. Questions Who were the participants of the SIOPE Annual Meeting? (01:00-02:29) What is the main message you wish to share […]

touchONCOLOGY were thrilled to speak to Editorial Board member Professor John Marshall (Medstar Georgetown University Hospital, Washington, DC, USA) to summarise the latest developments and data from the ASCO Gastrointestinal Cancers Symposium 2022. The phase III CheckMate 577 Study (NCT03044613): https://meetings.asco.org/abstracts-presentations/204867 KEYNOTE-062 (NCT02494583): https://meetings.asco.org/abstracts-presentations/204515 JCOG NExT study (UMIN000014795): https://meetings.asco.org/abstracts-presentations/204882 Questions: What have recent clinical study […]

Treatment options for myeloma have rapidly expanded in the past decade and, as with many cancers, the number of oral drug options has increased considerably. Given the more limited number of cancer hospitals, patients often must travel considerable distance to get to their closest cancer centre, which places a significant burden on receiving adequate therapy. […]

Gastro-oesophageal cancers (GEC), which include both gastric (GC) and oesophageal cancers (EC), are among the most common cancers globally.1 In the USA, the American Cancer Society estimated 20,640 new diagnoses of EC and 26,380 new diagnoses of GC, each contributing to 16,410 and 11,090 deaths, respectively, in 2022 alone.2,3 GEC is divided based on the histology of squamous […]

Cervical cancer (CC) remains one of the most frequent cancers in women, representing the fourth cause of neoplasia in women in terms of incidence, and has a high lethality rate.1 Indeed, worldwide 341,831 women die each year because of this disease, with a mortality rate that varies across different countries, with, for example, less than two […]

Welcome to the latest edition of touchREVIEWS in Oncology & Haematology. Despite the success of the human papillomavirus vaccination programme, cervical cancer remains one of the most common cancers in women, and advanced disease carries a poor prognosis. Lebreton et al. review data from the KEYNOTE-826 Phase III trial, which showed the benefits of adding pembrolizumab […]